Getinge reports good organic growth in Q2 2026
Sales grew 4.6% organically, adjusted EBITA margin 17.6%, and free cash flow improved.
See the latest news and media coverage for Getinge. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical technology company
getinge.comLast updated
In short: Getinge reported robust financial results through 2026, highlighted by strong organic growth, key acquisitions, and strategic partnerships.
Sales grew 4.6% organically, adjusted EBITA margin 17.6%, and free cash flow improved.
The combined entity accelerates innovation in transplant care, launching new products and entering new markets.
The MOHKI clinic, equipped with Getinge products, has treated over 70 children with congenital heart defects, including pioneering open-heart and TGA surgeries.
A jury found no infringement of Maquet's heart pump patents, with no financial impact.
Shareholders of Getinge AB (publ) ( STO:GETI B ) will be pleased this week, given that the stock price is up 10% to...
The Stockholm Stock Exchange closed in an irregular trend on Friday, when the earnings season peaked with a large number of heavyweights on the scene.
Getinge AB () has held its Q2 earnings call. Read on for the main highlights of the call. TipRanks Welcomes a New ETF – NYSE:RANK...
Getinge (OTCMKTS:GNGBY – Get Free Report) shares rose 9.2% during trading on Monday . The company traded as high as $23.70 and last traded at...
Track Getinge and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Getinge and other trending companies.